TR201716209A2 - New pharmaceutical compositions containing arformoterol and umeclidinium. - Google Patents

New pharmaceutical compositions containing arformoterol and umeclidinium. Download PDF

Info

Publication number
TR201716209A2
TR201716209A2 TR2017/16209A TR201716209A TR201716209A2 TR 201716209 A2 TR201716209 A2 TR 201716209A2 TR 2017/16209 A TR2017/16209 A TR 2017/16209A TR 201716209 A TR201716209 A TR 201716209A TR 201716209 A2 TR201716209 A2 TR 201716209A2
Authority
TR
Turkey
Prior art keywords
umeclidinium
arformoterol
pharmaceutical compositions
compositions containing
new pharmaceutical
Prior art date
Application number
TR2017/16209A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/16235A priority Critical patent/TR201716235A2/en
Publication of TR201716209A2 publication Critical patent/TR201716209A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Mevcut buluş astım ve KOAH (Kronik Obstrüktif Akciğer Hastalığı) tedavisinde kullanılacak arformoterol ve umeklidinyum içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions containing arformoterol and umeclidinium for use in the treatment of asthma and COPD (Chronic Obstructive Pulmonary Disease).

TR2017/16209A 2017-09-30 2017-10-20 New pharmaceutical compositions containing arformoterol and umeclidinium. TR201716209A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/16235A TR201716235A2 (en) 2017-09-30 2017-10-20 Pharmaceutical Composition Containing Multiple Active Ingredients for the Treatment of Respiratory Diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16203A TR201716203A1 (en) 2017-10-20 2017-10-20 New umeclidinium formulations.

Publications (1)

Publication Number Publication Date
TR201716209A2 true TR201716209A2 (en) 2019-05-21

Family

ID=67954794

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2017/16203A TR201716203A1 (en) 2017-09-30 2017-10-20 New umeclidinium formulations.
TR2017/16207A TR201716207A2 (en) 2017-10-18 2017-10-20 Pharmaceutical formulations containing vilanterol and umeclidinium.
TR2017/16209A TR201716209A2 (en) 2017-09-30 2017-10-20 New pharmaceutical compositions containing arformoterol and umeclidinium.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2017/16203A TR201716203A1 (en) 2017-09-30 2017-10-20 New umeclidinium formulations.
TR2017/16207A TR201716207A2 (en) 2017-10-18 2017-10-20 Pharmaceutical formulations containing vilanterol and umeclidinium.

Country Status (1)

Country Link
TR (3) TR201716203A1 (en)

Also Published As

Publication number Publication date
TR201716207A2 (en) 2019-05-21
TR201716203A1 (en) 2019-05-21

Similar Documents

Publication Publication Date Title
CY1123391T1 (en) (2S)-N-[(1S)-1-CYANO-2-PHYNYLATHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS INHIBITORS OF DIPEPTYLYPEPTIDASE I
MX2020004467A (en) Methods for treating or preventing asthma by administering an il-4r antagonist.
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201691481A1 (en) C5a inhibitors for the treatment of viral pneumonia
SA517381713B1 (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic dis-orders
MD3500241T2 (en) Combination therapy for COPD
BR112017003332A2 (en) use of il-17 antagonists to inhibit progression of structural damage in psoriatic arthritis patients
MX2018013742A (en) Crystal forms of crisaborole in free form and preparation method and use thereof.
BR112017023351A2 (en) fragile matrix multidrug compositions
EA201692278A1 (en) FORMOTHEROL AND BUDESONIDE COMBINATION FOR THE TREATMENT OF COPD
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
IL283469A (en) Inhalable compositions for use in the treatment of pulmonary diseases
SG10202000496XA (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
CL2008000973A1 (en) Compounds derived from 1-oxo-isoquinoline; preparation procedure; pharmaceutical composition; and its use in the treatment of chronic obstructive pulmonary diseases (COPD) and asthma.
EA201791689A1 (en) NEW COMPOSITIONS AND METHODS OF TREATMENT AND / OR PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
TR201716209A2 (en) New pharmaceutical compositions containing arformoterol and umeclidinium.
PH12016502284A1 (en) Cough medicine containing ambroxol hydrochloride
TR201716199A1 (en) New pharmaceutical compositions containing arformoterol and ipratropium.
MX2019001183A (en) Compositions for the treatment of pulmonary fibrosis.
MX2021015553A (en) Novel arginase inhibitors.
EA201890789A1 (en) CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES
EA201792282A1 (en) METHODS OF TREATMENT OF DISEASES
TR201722950A2 (en) New pharmaceutical compositions in the treatment of COPD.
TR201712424A2 (en) DRY POWDER INHALATION COMPOSITIONS
EA201990605A1 (en) SPRAYED THIOTROPY AND FORMOTEROL COMPOSITIONS